Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technolo-gies to basic science cancer researchers – to create an environ-ment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imag-ing adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Dr. Wu Received American Heart Association Merit Award

May 22, 2017

First-in-Human Ultrasound Molecular Imaging in Patients with Breast and Ovarian Lesions

April 3, 2017

Farewell, Willemieke Tummers

March 28, 2017

Soujanya Gade, Clinical Research Program Coordinator, Accepted to the Ph.D. Program in Clinical Psychology at Palo Alto University

March 20, 2017

  • Ophir Vermesh Received Bio-X Poster Award

    March 1, 2017…

MIPS collaboration with Chemistry leads to new functional delivery system of mRNA

February 16, 2017